Liver & Kidney Transplant Trial



General Surgery Hepatology Nephrology




Hepatology Nephrology Transplant Programs




Kidney Transplant Combination Drug Trial Kidney Transplant Drug Delivery Trial

Clinical Trial Protocol ID
04022606

Clinical Trial Investigator Name
S. Forrest Dodson, MD

Clinical Trial Title
Effectiveness Study of Changing Immunosuppressive Drugs in Kidney and Liver Patients Who Have Developed Abnormal Glucose Levels

Clinical Trial Protocol Description

This study will examine the effectiveness of changing immunosuppressive drugs in patients who have had a kidney or liver transplant within the past six months and have developed abnormal glucose levels. Patients will be randomly assigned to either maintain their current medication regimen or change to the study drug. The study will last 26 weeks.

Clinical Trial Eligibility Criteria

To be eligible, participants must:

Be at least 18 years old
Have had a kidney or liver transplant more than two months ago
Be taking immunosuppressant medication
Have abnormal glucose levels

This is a partial list of eligibility requirements.

Contact Name	Nancy Ebert, RN
Contact Phone	(312) 942-4252
Contact E-mail	clinical_trials@rush.edu



Clinical Trials Home Kidney Disease Clinical Trials Liver & Kidney Transplant Trial